Letter Regarding “Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial”

Detalles Bibliográficos
Autores principales: Aoki, Yuki, Kataoka, Yuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263251/
https://www.ncbi.nlm.nih.gov/pubmed/35812295
http://dx.doi.org/10.1016/j.ekir.2022.01.1075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263251/
https://www.ncbi.nlm.nih.gov/pubmed/35812295
http://dx.doi.org/10.1016/j.ekir.2022.01.1075

Ejemplares similares